Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology

Area of Science:

• Oncology
• Hematology

Background:

• Acute lymphoblastic leukemia (ALL) requires precise management strategies.
• Subtyping ALL based on immunophenotype and molecular markers is crucial for risk stratification.

Purpose of the Study:

• To present NCCN Clinical Practice Guidelines for ALL management.
• To focus on evidence-based treatment recommendations for adult, newly diagnosed, Philadelphia chromosome-negative ALL.

Main Methods:

• Guidelines development based on current evidence.
• Focus on risk-adapted therapy and treatment strategies.
• Inclusion of classification, risk assessment, and supportive care.

Main Results:

• Recommendations for classifying ALL subtypes.
• Stratification of patients for risk-adapted therapy.
• Specific treatment strategies for Ph-negative ALL in adults.

Conclusions:

• NCCN Guidelines provide a framework for managing adult Ph-negative ALL.
• Evidence-based recommendations support optimal patient care.
• Guidelines emphasize risk-adapted and supportive care approaches.